2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$20.45+$0.38 (+1.89%)
Price as of Oct 02, 2026 6:16 PM EDT- $7.0BMarket Cap
- 92.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$20.45+$0.38 (+1.89%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.07 | ||
Change | -$0.07 (-0.35%) | ||
Open | $20.13 | ||
High | $20.26 | ||
Low | $19.61 | ||
Previous Close | $20.14 | ||
Volume | 3,936,370 | ||
30-Day Average Volume | 2,832,535 | ||
1-Week Change | 1.34% | ||
1-Month Change | 13.52% | ||
1-Year Change | 92.98% | ||
3-Year Change | 375.59% | ||
5-Year Change | 262.27% | ||
Fundamentals | |||
Shares Outstanding | 348.3M | ||
Total Assets | $3.8B | ||
Market Cap | $7.0B | ||
Enterprise Value | $9.5B | ||
Period: QTR TTM FY | |||
Revenue | $796.2M | ||
Net Income | $57.7M | ||
Free Cash Flow | -$51.9M | ||
EBIT | $114.1M | ||
EBITDA | $149.0M | ||
Net Working Capital | $1.1B | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 212 | ||
P/E | 112 | ||
PEG | -21 | ||
Price/Free Cash Flow | -135 | ||
Price/Operating Cash Flow | -329 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue